From neuroanatomy to gene therapy: searching for new ways to manipulate the supraspinal endogenous pain modulatory system
- 25 June 2007
- journal article
- review article
- Published by Wiley in Journal of Anatomy
- Vol. 211 (2), 261-268
- https://doi.org/10.1111/j.1469-7580.2007.00759.x
Abstract
The endogenous pain modulatory system is a complex network of brain areas that control nociceptive transmission at the spinal cord by inhibitory and facilitatory actions. The balance between these actions ensures effective modulation of acute pain, while during chronic pain the pronociceptive effects appear to prevail. The mechanisms underlying this imbalance were studied as to the role of two medullary components of the pain modulatory system: the dorsal reticular nucleus and the caudal ventrolateral medulla, which function primarily as pronociceptive and antinociceptive centres, respectively. Both areas are connected with the spinal dorsal horn by closed reciprocal loops. In the spino-dorsal reticular nucleus loop, the ascending branch is strongly inhibited by spinal GABAergic neurons, which may act as a buffering system of the dorsal reticular nucleus-centred amplifying effect. In the spino-caudal ventrolateral medulla loop, the ascending branch is under potent excitation of substance P (SP) released from primary afferents, which is likely to trigger the intense descending inhibition detected in acute pain. During chronic pain, the activity in the lateral reticular formation of the caudal ventrolateral medulla changes, so that the action of the caudal ventrolateral medulla upon SP-responsive spinal neurons shifts from inhibitory to excitatory. The mechanisms of this modulatory shift are unknown but probably relate to the decreased expression of micro-opioid, delta-opioid and GABAB receptors. Normalizing receptor expression in the caudal ventrolateral medulla or controlling noci-evoked activity at the dorsal reticular nucleus or caudal ventrolateral medulla by interfering with neurotransmitter release is now possible by the use of gene therapy, an approach that stands out as a unique tool to manipulate the supraspinal endogenous pain control system.Keywords
This publication has 69 references indexed in Scilit:
- Brain projections from the medullary dorsal reticular nucleus: An anterograde and retrograde tracing study in the ratNeuroscience, 2006
- Remote Nerve Injection of Mu Opioid Receptor Adeno-associated Viral Vector Increases Antinociception of Intrathecal MorphineThe Journal of Pain, 2005
- 158. Gene Therapy for Chronic Pain Control: Perspectives of HSV-1 Mediated Gene Transfer to Supraspinal CentresMolecular Therapy, 2005
- Gene Therapy for Bladder Pain With Gene Gun Particle Encoding Pro-Opiomelanocortin cDNAJournal of Urology, 2003
- Noxious‐evoked c‐fos expression in brainstem neurons immunoreactive for GABAB, µ‐opioid and NK‐1 receptorsEuropean Journal of Neuroscience, 2003
- Descending control of painProgress in Neurobiology, 2002
- The ventrolateral medulla of the rat is connected with the spinal cord dorsal horn by an indirect descending pathway relayed in the A5 noradrenergic cell groupJournal of Comparative Neurology, 1996
- Spinal nociceptive transmission in the spontaneously hypertensive and Wistar-Kyoto normotensive ratPain, 1994
- Electrolytic lesions in the depressor area of the ventrolateral medulla of the rat abolish depressor responses to the aortic nerve stimulationBrain Research, 1989
- Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin CircuitryAnnual Review of Neuroscience, 1984